文献速递血液净化与透析

腹膜透析流出液蛋白质组学前瞻性研究鉴定包裹性腹膜硬化症潜在生物标志物

A prospective, proteomics study identified potential biomarkers of encapsulating peritoneal sclerosis in peritoneal effluent.
PubMed 文献 · Kidney Int · 2017-07-01

本研究利用全球液体研究前瞻性收集的腹膜透析患者流出液样本及希腊队列,采用二维电泳/质谱和iTRAQ技术,比较包裹性腹膜硬化症(EPS)患者与治疗暴露匹配对照的蛋白质组差异。在稳定膜功能患者中,纤维蛋白原γ链和硫酸乙酰肝素蛋白多糖核心蛋白随透析时间逐渐升高;EPS患者诊断前5年即出现胶原α1(I)、γ肌动蛋白及补体B和I升高,诊断前约1年或osomucoid-1和α2-HS糖蛋白B链升高,而载脂蛋白A-IV和α1-抗胰蛋白酶降低。动态范围压缩提高了低丰度蛋白检出,EPS患者中intelectin-1、皮肌腱蛋白、凝溶胶蛋白和视黄醇结合蛋白-4升高。

要点

  • EPS诊断前5年腹膜透析流出液中胶原α1(I)、γ肌动蛋白及补体B和I已升高。
  • 诊断前约1年或osomucoid-1和α2-HS糖蛋白B链升高,载脂蛋白A-IV和α1-抗胰蛋白酶降低。
  • 动态范围压缩技术可提高腹膜透析流出液低丰度蛋白的检出和分辨率。

核心结论

  • 腹膜透析流出液前瞻性蛋白质组分析发现提示炎症和促纤维化损伤的蛋白,值得进一步评估作为EPS诊断或预后标志物。

研究设计与样本

  • 研究基于全球液体研究前瞻性收集的样本及希腊腹膜透析患者队列,采用二维SDS-PAGE/质谱和iTRAQ技术,比较EPS患者与治疗暴露匹配对照的腹膜透析流出液蛋白质组,并使用组合肽配体库压缩蛋白浓度动态范围。

主要发现

  • 在膜功能稳定的患者中,纤维蛋白原γ链和硫酸乙酰肝素蛋白多糖核心蛋白随腹膜透析时间逐渐升高。
  • 在发生EPS的患者中,胶原α1(I)、γ肌动蛋白及补体B和I在诊断前长达5年即升高。
  • 或osomucoid-1和α2-HS糖蛋白B链在诊断前约1年升高,而载脂蛋白A-IV和α1-抗胰蛋白酶较对照降低。
  • 动态范围压缩增加了检出蛋白数量并改善了蛋白点分辨率。
  • 在EPS患者蛋白质组挖掘样本中,intelectin-1、皮肌腱蛋白、凝溶胶蛋白和视黄醇结合蛋白-4较刚开始腹膜透析的患者升高。

临床怎么用

  • 腹膜透析流出液中的上述蛋白变化可能有助于EPS的早期识别和风险分层,但需进一步验证后才能用于临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Encapsulating peritoneal sclerosis (EPS) is a potentially devastating complication of peritoneal dialysis (PD). Diagnosis is often delayed due to the lack of effective and accurate diagnostic tools. We therefore examined peritoneal effluent for potential biomarkers that could predict or confirm the diagnosis of EPS and would be valuable in stratifying at-risk patients and driving appropriate interventions. Using prospectively collected samples from the Global Fluid Study and a cohort of Greek PD patients, we utilized 2D SDSPAGE/ MS and iTRAQ to identify changes in the peritoneal effluent proteome from patients diagnosed with EPS and controls matched for treatment exposure. We employed a combinatorial peptide ligand library to compress the dynamic range of protein concentrations to aid identification of low-abundance proteins. In patients with stable membrane function, fibrinogen γ-chain and heparan sulphate proteoglycan core protein progressively increased over time on PD. In patients who developed EPS, collagen-α1(I), γ-actin and Complement factors B and I were elevated up to five years prior to diagnosis. Orosomucoid-1 and a2-HS-glycoprotein chain-B were elevated about one year before diagnosis, while apolipoprotein A-IV and α1-antitrypsin were decreased compared to controls. Dynamic range compression resulted in an increased number of proteins detected with improved resolution of protein spots, compared to the full fluid proteome. Intelectin-1, dermatopontin, gelsolin, and retinol binding protein-4 were elevated in proteome-mined samples from patients with EPS compared to patients that had just commenced peritoneal dialysis. Thus, prospective analysis of peritoneal effluent uncovered proteins indicative of inflammatory and pro-fibrotic injury worthy of further evaluation as diagnostic/prognostic markers.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Zavvos V, Buxton AT, Evans C, et al. A prospective, proteomics study identified potential biomarkers of encapsulating peritoneal sclerosis in peritoneal effluent. Kidney Int. 2017. PMID: 28673451. doi:10.1016/j.kint.2017.03.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。